American Journal of Clinical Nutrition, Vol 66, 633-638, Copyright © 1997 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Lipolytic sensitivity to catecholamines in patients with human immunodeficiency virus infection

R Heijligenberg, JA Romijn, S Klein, E Endert and HP Sauerwein
Department of Internal Medicine, Academic Hospital of Amsterdam University.

Lipolysis is higher in patients with acquired immunodeficiency syndrome (AIDS) than in healthy control subjects. To evaluate whether this increase in lipolysis is related to increased beta-adrenergic sensitivity, we compared the lipolytic response to epinephrine (approximately 15 ng x kg(-1) x min(-1)) of six AIDS patients with that of six matched control subjects. Lipolysis was measured by infusion of [2H2]glycerol and [2H2]palmitate. The baseline rates of appearance of palmitate (2.06 +/- 0.21 compared with 1.45 +/- 0.07 micromol x kg(-1) x min(-1)) and glycerol (2.35 +/- 0.16 compared with 1.35 +/- 0.06 micromol x kg(-1) x min(-1)) were higher in AIDS patients (P < 0.05). The absolute increase in lipolysis, an indicator of the responsiveness to epinephrine, was not different between groups for the rate of appearance of palmitate (86 +/- 14 compared with 75 +/- 7 micromol x L(- 1) x min(-1)) or glycerol (79 +/- 13 compared with 59 +/- 6 micromol x L(-1) x min(-1)). Plasma concentrations of epinephrine were not different between groups. Lipolysis was higher whereas the lipolytic response to epinephrine was normal in AIDS patients. Increased lipolytic sensitivity to catecholamines is not the cause of increased lipolysis in AIDS.

This article has been cited by other articles:

				W. T. Cade, D. N. Reeds, B. Mittendorfer, B. W. Patterson, W. G. Powderly, S. Klein, and K. E. Yarasheski Blunted lipolysis and fatty acid oxidation during moderate exercise in HIV-infected subjects taking HAART Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E812 - E819. [Abstract] [Full Text] [PDF]

				M. van der Valk, G. Allick, G. J. Weverling, J. A. Romijn, M. T. Ackermans, J. M. A. Lange, B. L. F. van Eck-Smit, C. van Kuijk, E. Endert, H. P. Sauerwein, et al. Markedly Diminished Lipolysis and Partial Restoration of Glucose Metabolism, without Changes in Fat Distribution after Extended Discontinuation of Protease Inhibitors in Severe Lipodystrophic Human Immunodeficient Virus-1-Infected Patients J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3554 - 3560. [Abstract] [Full Text] [PDF]

				M. M Buijs, J. Burggraaf, C. Wijbrandts, M. L de Kam, M. Frolich, A. F Cohen, J. A Romijn, H. P Sauerwein, A E. Meinders, and H. Pijl Blunted lipolytic response to fasting in abdominally obese women: evidence for involvement of hyposomatotropism Am. J. Clinical Nutrition, March 1, 2003; 77(3): 544 - 550. [Abstract] [Full Text] [PDF]

				M. van der Valk, P. Reiss, F. C. van Leth, M. T. Ackermans, E. Endert, J. A. Romijn, R. Heijligenberg, and H. Sauerwein Highly Active Antiretroviral Therapy-Induced Lipodystrophy Has Minor Effects on Human Immunodeficiency Virus-Induced Changes in Lipolysis, but Normalizes Resting Energy Expenditure J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5066 - 5071. [Abstract] [Full Text] [PDF]

				M. M. Buijs, J. Burggraaf, J. G. Langendonk, R. C. Schoemaker, M. Frolich, J.-W. Arndt, A. F. Cohen, J. A. Romijn, M. T. Ackermans, H. P. Sauerwein, et al. Hyposomatotropism Blunts Lipolysis in Abdominally Obese Women J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3851 - 3858. [Abstract] [Full Text] [PDF]